Spruce Biosciences, Inc. Common Stock (SPRB) is a publicly traded the market company. As of May 21, 2026, SPRB trades at $52.56 with a market cap of $138.92M and a P/E ratio of -1.02. SPRB moved +7.09% today. Year to date, SPRB is -37.27%; over the trailing twelve months it is +429.99%. Its 52-week range spans $4.28 to $240.00. Analyst consensus is strong buy with an average price target of $178.60. Rallies surfaces SPRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes SPRB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $52.56 |
| Market Cap | $138.92M |
| P/E Ratio | -1.02 |
| EPS | $-50.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $240.00 |
| 52-Week Low | $4.28 |
| Volume | 35 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-38.97M |
| Gross Margin | 0.00% |
5 analysts cover SPRB: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $178.60.